[go: up one dir, main page]

NO973401L - Corticosteroid-containing compositions and their preparation - Google Patents

Corticosteroid-containing compositions and their preparation

Info

Publication number
NO973401L
NO973401L NO973401A NO973401A NO973401L NO 973401 L NO973401 L NO 973401L NO 973401 A NO973401 A NO 973401A NO 973401 A NO973401 A NO 973401A NO 973401 L NO973401 L NO 973401L
Authority
NO
Norway
Prior art keywords
corticosteroid
preparation
containing compositions
liposomes
contained
Prior art date
Application number
NO973401A
Other languages
Norwegian (no)
Other versions
NO973401D0 (en
Inventor
Peter William Taylor
Janet Catherine Maas
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO973401D0 publication Critical patent/NO973401D0/en
Publication of NO973401L publication Critical patent/NO973401L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Farmasøytisk sammensetning, omfattende som aktivt ingrediens en forbindelse med formel (I). inneholdt i liposomer eller dehydrerte liposomer.Pharmaceutical composition, comprising as active ingredient a compound of formula (I). contained in liposomes or dehydrated liposomes.

NO973401A 1995-01-24 1997-07-23 Corticosteroid-containing compositions and their preparation NO973401L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9501286.0A GB9501286D0 (en) 1995-01-24 1995-01-24 Pharmaceutical compositions and preparations thereof
PCT/GB1996/000083 WO1996022764A1 (en) 1995-01-24 1996-01-17 Liposomes containing a corticosteroid

Publications (2)

Publication Number Publication Date
NO973401D0 NO973401D0 (en) 1997-07-23
NO973401L true NO973401L (en) 1997-07-23

Family

ID=10768424

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973401A NO973401L (en) 1995-01-24 1997-07-23 Corticosteroid-containing compositions and their preparation

Country Status (10)

Country Link
EP (1) EP0859598A1 (en)
JP (1) JPH10512876A (en)
CN (1) CN1169115A (en)
AU (1) AU4396196A (en)
CA (1) CA2210482A1 (en)
CZ (1) CZ234297A3 (en)
FI (1) FI973049A0 (en)
GB (1) GB9501286D0 (en)
NO (1) NO973401L (en)
WO (1) WO1996022764A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1019417B1 (en) 1997-08-18 2002-10-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Phospholipid analogue compounds
EP1133301A1 (en) * 1998-11-26 2001-09-19 Britannia Pharmaceuticals Limited Anti-asthmatic combinations comprising surface active phospholipids
GB9912639D0 (en) 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
ATE458471T1 (en) 1999-05-27 2010-03-15 Euro Celtique Sa FORMULATIONS CONTAINING POVIDONE IODINE FOR THE TREATMENT OF WOUNDS
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
WO2001066561A1 (en) * 2000-03-09 2001-09-13 Kissei Pharmaceutical Co., Ltd. Preventive or therapeutic drugs for eye diseases
GB0029562D0 (en) * 2000-12-04 2001-01-17 Novartis Ag Organic compounds
DE10255285A1 (en) * 2002-11-26 2004-06-03 Mcs Micro Carrier Systems Gmbh Self-forming phospholipid gels
WO2008029763A1 (en) * 2006-09-05 2008-03-13 Q.P. Corporation Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607028A (en) * 1983-08-18 1986-08-19 Ciba-Geigy Corporation Novel carboxylic acid esters
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
SE8603812D0 (en) * 1986-09-12 1986-09-12 Draco Ab ADMINISTRATION OF LIPOSOMES TO MAMMALS
US5043165A (en) * 1988-12-14 1991-08-27 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs

Also Published As

Publication number Publication date
AU4396196A (en) 1996-08-14
FI973049A7 (en) 1997-07-18
JPH10512876A (en) 1998-12-08
GB9501286D0 (en) 1995-03-15
NO973401D0 (en) 1997-07-23
CZ234297A3 (en) 1997-10-15
CN1169115A (en) 1997-12-31
EP0859598A1 (en) 1998-08-26
WO1996022764A1 (en) 1996-08-01
FI973049L (en) 1997-07-18
CA2210482A1 (en) 1996-08-01
MX9705592A (en) 1997-11-29
FI973049A0 (en) 1997-07-18

Similar Documents

Publication Publication Date Title
KR890700125A (en) New benzimidazole derivatives, preparation method thereof and pharmaceutical composition containing the compound
NO971889D0 (en) Compounds and compositions for delivery of active agents
MY115339A (en) Compositions containing micronized nebivolol
AU5669298A (en) Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
SE9504661D0 (en) New compounds
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
SE8804629D0 (en) NEW THERAPEUTICALLY ACTIVE COMPOUNDS
MY101791A (en) New benzimidazole derivatives
MD1233C2 (en) Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
NO954072D0 (en) Water-soluble camptothecin derivatives, processes for their preparation and their use as antitumor agents
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
ES2002140A6 (en) Transdermally resorbable aqueous compositions of arylpropionic-acid derivatives and process for their preparation.
UA48958C2 (en) 9-0-oxime derivatives of erythromycine and pharmaceutical composition thereof
FI945780A7 (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and method for their preparation
FI943645A7 (en) Novel baccatin-III and 10-deacetylbaccatin-III derivatives, their preparation and pharmaceutical compositions containing them
NO973401L (en) Corticosteroid-containing compositions and their preparation
PH27446A (en) Compound with gastric acid inhibitory effect
DE69819539D1 (en) ANTITHROMBOTIC AGENTS
SE9504662D0 (en) New compounds
CA2263846A1 (en) Novel pyranoside derivatives
SE9403137D0 (en) Derivatives of carbohydrates and compositions containing them
AU7470098A (en) Antithrombotic agents
NO960812L (en) Alkoxy-substituted ptors
DE69829849D1 (en) Streptogamin derivatives, their preparation and preparations containing them

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application